Stock Updates

A look at a High Market Cap Stock: Celgene Corporation, CELG

Celgene Corporation, CELG is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Celgene Corporation, CELGĀ  has a market cap of 81986.42. Since its IPO date on the 3/26/1990, Celgene Corporation, CELG performance year to date is -12.30%. Today Celgene Corporation, CELG has gained 0.59%, with a current price of 105.03.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 80.40%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 6.90%, with return on investment at 8.90%.

In terms of debt levels and profit levels, Celgene Corporation, CELG is seeing a long-term debt/equity of 2.81. While Total debt/equity is 0. With a profit margin of 17.40%, this is combined with a gross margin of 95.60%, and operating margin of 24.50%. Celgene Corporation ability to meet debt levels, with a current ratio of 4.6, while the quick ratio is 4.3.

For the last year Celgene Corporation, CELG has seen a EPS growth of -18.80%. A performance for the year of -10.13%. The 52-week high is -25.36%, and the 52-week low is 12.96%. The average volume for Celgene Corporation, CELG is 3369607.

With a target price of 136.38, can Celgene Corporation, CELG reach this target? Looking at the value indicators of Celgene Corporation, CELG. Celgene Corporation has a P/E of 50.81 and a forward P/E of 15.02. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.3. Celgene Corporation also has a P/S and a P/B of 8.46 and 16.16 respectively. For P/cash, Celgene Corporation has a value of 14.37, while it is 35.67 for P/free cash flow.

At the current price of 105.03, Celgene Corporation has a dividend yield of *TBA. We see a return on equity of 29.70%.

Looking more long-term Celgene Corporation, is projected to get an EPS growth for the next five years of 22.06%. In the short-term an EPS growth of 23.32% in the next year is forecasted. This is after a EPS growth of -18.80% for this year and for the last five years a 15.70% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment